Our Services
Medical Information
Helpful Resources
Published on: 9/22/2026
Hormone testing is not a required step for diagnosing narcolepsy, since the diagnosis rests on clinical history plus sleep testing such as overnight polysomnography, a multiple sleep latency test, and in some cases cerebrospinal fluid hypocretin (orexin) measurement. That said, clinicians frequently order bloodwork first, including thyroid function, iron studies, blood sugar, and sometimes testosterone or cortisol, because hormonal and metabolic conditions can mimic the excessive daytime sleepiness seen in narcolepsy. Timing, symptom pattern, medication use, and other sleep disorders like sleep apnea all influence whether hormone labs are worth doing beforehand, and there are important nuances explained below that should be considered before requesting or skipping these tests.
Because sleepiness has many overlapping causes, the fastest way to know whether hormone labs, a sleep study, or something else should come first is to organize your symptoms now: take a free, instant, online symptom check to see which conditions best match what you are experiencing. It takes only a few minutes, requires no appointment, and gives you clear, personalized questions to bring to your doctor so you avoid unnecessary delays and unneeded tests.
Last reviewed for medical accuracy: 09/22/2026
Menopause hormone testing before narcolepsy diagnosis
When excessive daytime sleepiness or sudden “sleep attacks” impair your daily life, narcolepsy may be on your radar. But for women in midlife, fluctuating hormone levels—especially around menopause—can produce similar symptoms. Before moving straight to specialized sleep studies, it’s worth asking: should hormone levels be tested before a narcolepsy diagnosis? Understanding how menopause and narcolepsy overlap can help you and your doctor choose the right tests and get an accurate diagnosis faster.
What is narcolepsy?
Narcolepsy is a chronic neurological disorder that affects the brain’s ability to regulate sleep and wakefulness. Its hallmark symptoms include:
A formal narcolepsy diagnosis typically requires:
Menopause and sleep disruption
Menopause—and the years leading up to it (perimenopause)—brings fluctuating estrogen and progesterone levels. These hormonal shifts can trigger:
Because these symptoms overlap with narcolepsy (especially daytime sleepiness and concentration problems), a hormone imbalance can sometimes be misinterpreted as a primary sleep disorder.
Why consider menopause hormone testing before narcolepsy diagnosis?
Which hormone tests make sense?
• Sex hormones
– Estradiol (E2)
– Progesterone
– Follicle-stimulating hormone (FSH)
– Luteinizing hormone (LH)
• Thyroid panel
– Thyroid-stimulating hormone (TSH)
– Free T4 and T3
• Adrenal function
– Morning cortisol
– Dehydroepiandrosterone sulfate (DHEA-S)
• Others as clinically indicated
– Prolactin
– Vitamin D
When to test hormone levels
• Age and symptoms
– Women aged 45–55 with irregular periods, hot flashes or mood swings.
– Persistent fatigue that doesn’t improve with sleep hygiene or caffeine moderation.
• Physical exam findings
– Signs of thyroid disease (weight changes, heart rate irregularities).
– Skin, hair or nail changes suggesting endocrine imbalance.
• Lab availability and timing
– Sex hormone levels vary throughout the menstrual cycle and perimenopause; your doctor will advise on optimal timing (often early follicular phase for pre-menopausal women).
Integrating hormone testing into a narcolepsy workup
Pros and cons of hormone testing before narcolepsy evaluation
Pros
Cons
Practical steps you can take today
When to seek urgent medical attention
Conclusion
Hormone testing—especially during perimenopause and menopause—can be a valuable step in sorting out whether your persistent daytime sleepiness stems from an endocrine imbalance or a primary sleep disorder like narcolepsy. By checking thyroid function, adrenal hormones and sex steroids before or alongside sleep studies, you and your doctor can often arrive at a clearer diagnosis and more targeted treatment plan. If you’re unsure where to start, try a free, online symptom check, using the doctor approved Ubie Symptom Checker, then schedule a visit with your healthcare provider. Above all, speak to a doctor about any symptoms that could be life threatening or serious.
(References)
* Olejniczak PW, Fisch BJ. Sleep disorders. Med Clin North Am. 2003 Jul;87(4):803-33. doi: 10.1016/s0025-7125(03)00006-3. PMID: 12834150.
* Dauvilliers Y, Buguet A. Hypersomnia. Dialogues Clin Neurosci. 2005;7(4):347-56. doi: 10.31887/DCNS.2005.7.4/ydauvilliers. PMID: 16416710; PMCID: PMC3181743.
* Dauvilliers Y, Schenck CH, Postuma RB, Iranzo A, Luppi PH, Plazzi G, Montplaisir J, Boeve B. REM sleep behaviour disorder. Nat Rev Dis Primers. 2018 Aug 30;4(1):19. doi: 10.1038/s41572-018-0016-5. Epub 2018 Aug 30. PMID: 30166532.
* K Pavlova M, Latreille V. Sleep Disorders. Am J Med. 2019 Mar;132(3):292-299. doi: 10.1016/j.amjmed.2018.09.021. Epub 2018 Oct 4. PMID: 30292731.
* Lucien JN, Ortega MT, Shaw ND. Sleep and Puberty. Curr Opin Endocr Metab Res. 2021 Apr;17:1-7. doi: 10.1016/j.coemr.2020.09.009. Epub 2020 Oct 9. PMID: 35005296; PMCID: PMC8730357.
* Howell M, Avidan AY, Foldvary-Schaefer N, Malkani RG, During EH, Roland JP, McCarter SJ, Zak RS, Carandang G, Kazmi U, Ramar K. Management of REM sleep behavior disorder: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2023 Apr 1;19(4):759-768. doi: 10.5664/jcsm.10424. PMID: 36515157; PMCID: PMC10071384.
* Shan L, Linssen S, Harteman Z, den Dekker F, Shuker L, Balesar R, Breesuwsma N, Anink J, Zhou J, Lammers GJ, Swaab DF, Fronczek R. Activated Wake Systems in Narcolepsy Type 1. Ann Neurol. 2023 Oct;94(4):762-771. doi: 10.1002/ana.26736. Epub 2023 Jul 19. PMID: 37395722.
* Wang W, Shan L, Han F. Narcolepsy type 1: an autoimmune disease. Trends Mol Med. 2026 Jun;32(6):611-612. doi: 10.1016/j.molmed.2026.02.005. Epub 2026 Mar 12. PMID: 41826145.
* Woodliff B, Benjamin R. Pediatric Narcolepsy. 2026 Jan. PMID: 42044244.
* Mahoney CE, De Luca R, Joyal AA, Woods C, Zhao W, Coffey AA, Kurimoto E, Kroeger D, Zhu L, Fenselau H, Grinevich V, Burgess CR, Arrigoni E, Scammell TE. Oxytocin promotes socially triggered cataplexy. Nat Neurosci. 2026 Aug;29(8):1931-1941. doi: 10.1038/s41593-026-02352-7. Epub 2026 Jul 14. PMID: 42449131.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.